Target intelligence / Profile preview

Streptococcus pneumoniae (whole cell) (S. pneumoniae)

Target
S. pneumoniae
Molecular classification
Bacterium, Gram-positive bacterium, Pathogen
01

Overview

Streptococcus pneumoniae, also known as pneumococcus, is a Gram-positive bacterium responsible for diseases such as pneumonia, meningitis, otitis media, and sepsis. Key features include its thick peptidoglycan cell wall, polysaccharide capsule (with over 98 serotypes), and various surface proteins involved in adhesion and immune evasion. Virulence factors like pneumolysin and the capsule contribute to its pathogenicity. Its high genetic diversity and phase variation impact vaccine effectiveness and antibiotic resistance. As a whole cell target it includes all structural features: thick cell wall with unique modifications/residues important for survival/virulence; diverse capsular types critical for vaccine design/effectiveness; multiple surface-exposed proteins mediating adhesion/immune modulation.

Other names
Pneumococcus
02

Mechanism of action

Antibiotics target various bacterial processes (e.g., cell wall synthesis, protein synthesis, DNA replication). Vaccines induce antibody production against capsular polysaccharides or surface proteins.

03

Biological functions

ColonizationAdhesionInfectionImmune evasionBiofilm formation
04

Disease associations

PneumoniaMeningitisOtitis mediaSepsisInvasive pneumococcal disease (IPD)
05

Safety considerations

Antibiotic resistanceVaccine serotype replacementInvasive disease complicationsInflammatory response
06

Interacting drugs

Penicillin

5 more in the full profile.

07

Biomarkers

Capsular serotype (for vaccine effectiveness)Antibiotic resistance genesPneumolysin levelsCbpA/PspA expression

Beyond the preview

Go deeper on Streptococcus pneumoniae (whole cell) (S. pneumoniae).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae (whole cell) (S. pneumoniae).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call